Supplementary Tables from Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients

Andrew P. Garner,Joseph M. Gozgit,Rana Anjum,Sadanand Vodala, Alexa Schrock, Tianjun Zhou,Cesar Serrano,Grant Eilers,Meijun Zhu, Julia Ketzer,Scott Wardwell,Yaoyu Ning, Youngchul Song,Anna Kohlmann,Frank Wang,Tim Clackson,Michael C. Heinrich,Jonathan A. Fletcher, Sebastian Bauer, Victor M. Rivera

crossref（2023）

引用 0|浏览0

暂无评分

摘要

Supplementary Tables. Table S1. In Vitro Kinase IC50 Values (nM) for Native and Mutant Recombinant KIT. Table S2. Summary of Ba/F3 KIT Cell Lines Generated in this Study. Table S3. Summary of IC50 Viability Values in Ba/F3 KIT Cells. Table S4. Summary of KIT Driven Ba/F3 In Vivo Studies.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要